The studies indicate the importance of surface functionalization of carbon-encapsulated iron nanomaterials with monoclonal antibodies selectively recognizing the beta 3 subunit of the αvβ3 integrin receptor in targeted dynamic susceptibility contrast magnetic resonance imaging in CD61-positive glioma cells. This evidence concerns the gene ITGB3 and glioma.